TERESA SIMAS: Open Payments
NPI 1194810739 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 38 payments from 20 companies in 2025. Trend: 2023 $298 · 2024 $543 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 8 | $149 |
| ABBVIE INC. | 2 | $120 |
| ABIOMED | 3 | $97 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| SHIELD THERAPEUTICS INC | 3 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Nalu Medical, Inc. | 1 | $32 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $31 |
Products named: RECORLEV, QULIPTA, REXULTI, Auvelity, ACCRUFER, JARDIANCE, Nalu Neurostimulation System, ISTURISA.
Industry payments across CA — which companies pay providers there.
